Navin Shah, MD
Urology · Greenbelt, MDNPI 1346225000
Payments from drug & device makers
Across 274 payments — averaging $22.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Astellas Pharma US Inc$668
- Endo Pharmaceuticals Inc.$381
- Dendreon Pharmaceuticals LLC$363
- AbbVie$335
- Pfizer$329
- plus $3K from 29 others
What the payments were for
- Food & beverage$5,85796%
- Education$2224%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 51 | $1,240 |
| Astellas Pharma US Inc | 29 | $668 |
| Endo Pharmaceuticals Inc. | 18 | $381 |
| Dendreon Pharmaceuticals LLC | 15 | $363 |
| AbbVie(2 entities) | 16 | $335 |
| Pfizer | 17 | $329 |
| Sumitomo Pharma America, Inc. | 15 | $327 |
| Tolmar, Inc. | 10 | $286 |
| Bayer | 12 | $278 |
| Tolmar Pharmaceuticals, Inc. | 10 | $204 |
| Myovant Sciences Inc. | 8 | $201 |
| Ferring Pharmaceuticals Inc. | 9 | $161 |
| Antares Pharma, Inc. | 8 | $158 |
| Endo USA, Inc. | 5 | $123 |
| Alnylam Pharmaceuticals Inc. | 4 | $95 |
| Novartis | 3 | $88 |
| Urovant Sciences Inc | 5 | $88 |
| Boston Scientific | 5 | $87 |
| Accord Healthcare, Inc. | 4 | $84 |
| Blue Earth Diagnostics | 4 | $81 |
| Acerus Pharmaceuticals Corporation | 3 | $57 |
| Olympus America Inc. | 3 | $56 |
| Amgen | 2 | $53 |
| Myriad Genetic Laboratories, Inc. | 3 | $48 |
| Laborie Medical Technologies Corp. | 2 | $46 |
| Merck | 2 | $43 |
| Medtronic | 2 | $43 |
| Convatec Inc. | 1 | $28 |
| AstraZeneca | 1 | $23 |
| Clarus Therapeutics Inc. | 2 | $22 |
| Telix Pharmaceuticals | 1 | $20 |
| Foundation Medicine, Inc. | 1 | $18 |
| Axonics, Inc. | 1 | $16 |
| Neotract Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $14 |
How this compares
$6,080 in reported general payments places this provider in the 50th percentile of 274 urology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Greenbelt
- Jonah MurdockGreenbelt$23K
- Matthew AllawayCumberland$20.6M
- Ronald TutroneBaltimore$18.1M
- Mohamad AllafBaltimore$7.1M
- Max KatesBaltimore$1000K
- Benjamin LowentrittBaltimore$994K
- Rian DicksteinHanover$750K
- Laura GiustoOwings Mills$628K
- Kenneth LangerBaltimore$610K
- Arvin GeorgeBaltimore$518K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.